CLINICAL_TRIALS
trial_result
· 2013-08-13
Clinical Trial Update: Vitreous Levels of Cysteine-rich 61 in Patients With Proliferative Diabetic Retinopathy [NA]
Summary
This is a completed clinical trial evaluating vitreous levels of Cysteine-rich 61 in patients with proliferative diabetic retinopathy.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: National Taiwan University Hospital | Conditions: Proliferative Diabetic Retinopathy | NA | Status: COMPLETED